Document Detail

Chemopreventive effects of Ginkgo biloba extract in estrogen-negative human breast cancer cells.
MedLine Citation:
PMID:  23335025     Owner:  NLM     Status:  Publisher    
Excessive level of estrogen is considered as a main cause of breast cancer, therefore, many studies have focused on estrogen receptor (ER)-positive breast cancer, even though ER-negative cancer has a poor prognosis than ER-positive breast cancer. We evaluated the anti-cancer effects of Ginkgo biloba extract (GBE) in estrogen-independent breast cancer. GBE has been traditionally used as a platelet activating factor, a circulatory stimulant, a tonic, and anti-asthmatic drug, and anti-cancer agent. However, anti-cancer effects of GBE on ER-negative breast cancer have not been proved yet. In this study, we tested chemotherapeutic potential of GBE in the MDA-MB-231 (ER-negative) human breast cancer cell line. Our results showed that cytotoxicity effects of GBE in MDA-MB-231 lead to DNA fragmentation at high concentrations (500 and 1,000 μg/ml). Caspase-3 was significantly activated and mRNA levels of apoptosis-related genes (Bcl-2 and Bax) were altered. These results indicate that GBE induces apoptosis in MDA-MB-231 cells. It is presumed that GBE has chemopreventive effects in ER-independent breast cancer through anti-proliferation and apoptosis-inducing activities.
Yong Joo Park; Mi Jie Kim; Ha Ryong Kim; Min Sun Yi; Kyu Hyuck Chung; Seung Min Oh
Related Documents :
7866975 - Breast cancer survivors: concerns and coping.
12673975 - Cancer rehabilitation: does it make a difference?
21778285 - The legacy of sperm banking: how fertility monitoring and disposal of sperm are linked ...
15227715 - Rethinking research on psychosocial interventions in biopsychosocial oncology: an essay...
22647265 - Reduction of dietary glycaemic load modifies the expression of microrna potentially ass...
18996655 - Postmenopausal hormone drugs and breast and colon cancer: nordic countries 1995-2005.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-19
Journal Detail:
Title:  Archives of pharmacal research     Volume:  -     ISSN:  0253-6269     ISO Abbreviation:  Arch. Pharm. Res.     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-21     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8000036     Medline TA:  Arch Pharm Res     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
School of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-do, 440-746, Korea.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A novel canine model for prostate cancer.
Next Document:  Electroencephalographic monitoring in the pediatric intensive care unit.